Literature DB >> 30981756

Smoking cessation in people with serious mental illness.

A Eden Evins1, Corinne Cather2, Gail L Daumit3.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 30981756      PMCID： PMC7301342          DOI： 10.1016/S2215-0366(19)30139-7

Source DB:  PubMed          Journal:  Lancet Psychiatry        ISSN： 2215-0366            Impact factor:   27.083


× No keyword cloud information.
  8 in total

Review 1.  2018 ACC Expert Consensus Decision Pathway on Tobacco Cessation Treatment: A Report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents.

Authors:  Rajat S Barua; Nancy A Rigotti; Neal L Benowitz; K Michael Cummings; Mohammad-Ali Jazayeri; Pamela B Morris; Elizabeth V Ratchford; Linda Sarna; Eric C Stecker; Barbara S Wiggins
Journal:  J Am Coll Cardiol       Date:  2018-12-05       Impact factor: 24.094

2.  Neuropsychiatric Safety and Efficacy of Varenicline, Bupropion, and Nicotine Patch in Smokers With Psychotic, Anxiety, and Mood Disorders in the EAGLES Trial.

Authors:  A Eden Evins; Neal L Benowitz; Robert West; Cristina Russ; Thomas McRae; David Lawrence; Alok Krishen; Lisa St Aubin; Melissa Culhane Maravic; Robert M Anthenelli
Journal:  J Clin Psychopharmacol       Date:  2019 Mar/Apr       Impact factor: 3.153

3.  Maintenance treatment with varenicline for smoking cessation in patients with schizophrenia and bipolar disorder: a randomized clinical trial.

Authors:  A Eden Evins; Corinne Cather; Sarah A Pratt; Gladys N Pachas; Susanne S Hoeppner; Donald C Goff; Eric D Achtyes; David Ayer; David A Schoenfeld
Journal:  JAMA       Date:  2014-01-08       Impact factor: 56.272

4.  Cigarette Smoking and Quitting-Related Factors Among US Adult Health Center Patients with Serious Mental Illness.

Authors:  Sara Kalkhoran; Anne N Thorndike; Nancy A Rigotti; Vicki Fung; Travis P Baggett
Journal:  J Gen Intern Med       Date:  2019-02-19       Impact factor: 5.128

5.  It's time to change the default for tobacco treatment.

Authors:  Kimber P Richter; Edward F Ellerbeck
Journal:  Addiction       Date:  2014-10-16       Impact factor: 6.526

Review 6.  Interventions for smoking cessation and reduction in individuals with schizophrenia.

Authors:  Daniel T Tsoi; Mamta Porwal; Angela C Webster
Journal:  Cochrane Database Syst Rev       Date:  2013-02-28

7.  Varenicline for smoking cessation in bipolar disorder: a randomized, double-blind, placebo-controlled study.

Authors:  K N Roy Chengappa; Kenneth A Perkins; Jaspreet S Brar; Patricia J Schlicht; Scott R Turkin; Michelle L Hetrick; Michele D Levine; Tony P George
Journal:  J Clin Psychiatry       Date:  2014-07       Impact factor: 4.384

8.  Smoking cessation for people with severe mental illness (SCIMITAR+): a pragmatic randomised controlled trial.

Authors:  Simon Gilbody; Emily Peckham; Della Bailey; Catherine Arundel; Paul Heron; Suzanne Crosland; Caroline Fairhurst; Catherine Hewitt; Jinshuo Li; Steve Parrott; Tim Bradshaw; Michelle Horspool; Elizabeth Hughes; Tom Hughes; Suzy Ker; Moira Leahy; Tayla McCloud; David Osborn; Joe Reilly; Thomas Steare; Emma Ballantyne; Polly Bidwell; Sue Bonner; Diane Brennan; Tracy Callen; Alex Carey; Charlotte Colbeck; Debbie Coton; Emma Donaldson; Kimberley Evans; Hannah Herlihy; Wajid Khan; Lizwi Nyathi; Elizabeth Nyamadzawo; Helen Oldknow; Peter Phiri; Shanaya Rathod; Jamie Rea; Crystal-Bella Romain-Hooper; Kaye Smith; Alison Stribling; Carinna Vickers
Journal:  Lancet Psychiatry       Date:  2019-04-08       Impact factor: 27.083
  8 in total
  1 in total

1.  Prevalence of smoking, quit attempts and access to cessation treatment among adults with mental illness in Brazil: a cross-sectional analysis of a National Health Survey.

Authors:  Erica Cruvinel; Edward Liebman; Isabel Leite; Jinxiang Hu; Kimber P Richter
Journal:  BMJ Open       Date:  2020-05-26       Impact factor: 2.692
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.